WILMINGTON, Del.—Chemours saw sales in its fluoropolymer segment increase by 24 percent in the second quarter.
According to its financial report, the unit posted sales of $710 million on a 23 percent increase in sales volume for fluoropolymers, Chemours said.
EBITDA in the segment increased by 87 percent to $297 million for the quarter, up from $105 million in 2016.
Overall, Chemours reported $3 billion in net sales for the first six months, up from $2.7 billion in 2016. Net profit came in at $799 million, a significant increase compared to $468 million in 2016.
Chemours CEO Mark Vergano said the firm's Opteon refrigerants and blowing agents are benefiting from an "adoption ramp-up," which he said remains in full force. The project has led to double-digit volume growth reported within the firm's fluoropolymers business.